Status:
COMPLETED
CD16+ Monocytes in Coronary Heart Disease (CHD)
Lead Sponsor:
Martin-Luther-Universität Halle-Wittenberg
Conditions:
Coronary Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
Monocytes may be separated into phenotypically and functionally distinct cell types by the presence or absence of the lipopolysaccharide receptor CD14 and the Fcγ-receptor CD16. The investigators hypo...
Eligibility Criteria
Inclusion
- angiographically proven coronary heart disease
- Age \> 18 years
Exclusion
- life expectancy \< 12 months
- inability to participate in the trial (to give written informed consent)
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01442948
Start Date
May 1 2007
End Date
December 1 2010
Last Update
September 29 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic of the Martin Luther-University Halle-Wittenberg
Halle, Please Select, Germany, 06120